Volver a Agenda
Session Chair(s)
Mary Oates, PHD
Vice President, Innovative Operations and Network Excellence
Pfizer Inc, United States
Learning Objective : Define the characteristics of a quality culture; Recognize knowledge and tools that will facilitate culture enhancement.
Speaker(s)
FDA Point of View on Culture of Quality
Christine Moore, PHD
Organon & Co., United States
Executive Director, Global External Advocacy and Standards
Quantifying Quality Culture at an API CMO
Guy Villax
Hovione , Portugal
Chief Executive Officer
Developing and Embracing a Culture of Quality Beyond the Manufacturing Environment
David A. Tainsh, PHD, RPH
GlaxoSmithKline, United Kingdom
Chief Product Quality Officer, Governance, Ethics and Assurance
¿Tiene una cuenta?